tradingkey.logo
搜尋

Neogenomics Inc

NEO
添加自選
14.970USD
+0.380+2.60%
收盤 07/01, 16:00美東報價延遲15分鐘
1.95B總市值
虧損本益比TTM

關於 Neogenomics Inc 公司

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Neogenomics Inc簡介

公司代碼NEO
公司名稱Neogenomics Inc
上市日期Dec 10, 2012
CEOZook (Antony P)
員工數量2200
證券類型Ordinary Share
年結日Dec 10
公司地址9490 Neogenomics Way
城市FORT MYERS
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編33912
電話12397680600
網址https://neogenomics.com/
公司代碼NEO
上市日期Dec 10, 2012
CEOZook (Antony P)

Neogenomics Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
220.01K
+0.96%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
164.03K
+3.45%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
75.42K
+30.60%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
51.18K
+45.09%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
30.24K
+76.32%
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
22.96K
--
Ms. Lynn A. Tetrault, J.D.
Ms. Lynn A. Tetrault, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alison L. Hannah, M.D.
Dr. Alison L. Hannah, M.D.
Independent Director
Independent Director
--
--
Mr. Michael A. Kelly
Mr. Michael A. Kelly
Lead Independent Director
Lead Independent Director
--
--
Mr. David B. Perez
Mr. David B. Perez
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey Scott (Jeff) Sherman
Mr. Jeffrey Scott (Jeff) Sherman
Chief Financial Officer
Chief Financial Officer
220.01K
+0.96%
Mr. Warren Stone
Mr. Warren Stone
President, Chief Operating Officer
President, Chief Operating Officer
164.03K
+3.45%
Mr. Stephen Michael Kanovsky
Mr. Stephen Michael Kanovsky
Independent Director
Independent Director
75.42K
+30.60%
Dr. Neil Gunn
Dr. Neil Gunn
Independent Director
Independent Director
51.18K
+45.09%
Ms. Felicia Williams
Ms. Felicia Williams
Independent Director
Independent Director
30.24K
+76.32%
Ms. Marjorie C. Green
Ms. Marjorie C. Green
Independent Director
Independent Director
22.96K
--

常見問題

Neogenomics Inc的前五大股東是誰?

Neogenomics Inc的前五大股東如下:Mr. Jeffrey Scott (Jeff) Sherman

有多少機構持有Neogenomics Inc(NEO)的股份?

截至2026Q1,共有564家機構持有Neogenomics Inc的股份,合計持有的股份價值約為156.61M,占公司總股份的120.32% 。與2025Q4相比,機構持股有所增加,增幅為7515333.00。

哪個業務部門對Neogenomics Inc的收入貢獻最大?

在2026Q1,Clinical Services-Client direct billing業務部門對Neogenomics Inc的收入貢獻最大,創收518.84M,占總收入的71.34% 。